Underutilization of best systemic therapy in patients with metastatic prostate cancer.

被引：0
|
作者：
Roadman, Daniel
Cao, David
Vourganti, Srinivas
机构：
[1] Rush Univ, Med Ctr, Chicago, IL USA
[2] Graham Med Grp, Canton, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
111
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cabozantinib plus androgen deprivation therapy in patients with androgen-dependent metastatic prostate cancer.
    Corn, Paul Gettys
    Zurita, Amado J.
    Subudhi, Sumit Kumar
    Tu, Shi-Ming
    Aparicio, Ana
    Araujo, John C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [22] Patterns of response to androgen deprivation therapy in younger patients with locally advanced or metastatic prostate cancer.
    Keating, Matthew
    Giscombe, Lisa
    Desouza, Andre
    Mukkamalla, Shiva Kumar Reddy
    Rathore, Ritesh
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] Impact of cytoreductive nephretomy on timing of systemic therapy in metastatic kidney cancer.
    Macleod, Liam Connor
    Dash, Atreya
    Schade, George
    Harper, Jonathan D.
    Lin, Daniel W.
    Tykodi, Scott S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [24] Utilization of systemic therapy options in the routine treatment of metastatic colorectal cancer.
    Delahunty, Rachel Lee
    Lee, Margaret
    Wong, Hui-Li
    McKendrick, Joseph James
    Lee, Belinda
    Kosmider, Suzanne
    Cooray, Prasad
    Ananda, Sumitra
    Tran, Ben
    Tie, Jeanne
    Desai, Jayesh
    Gibbs, Peter
    Wong, Rachel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [25] Systemic therapy of prostate cancer in elderly patients
    von Amsberg, Gunhild
    Busenbender, Tobias
    Tilki, Derya
    Bokemeyer, Carsten
    ONKOLOGIE, 2024, 30 (02): : 119 - 128
  • [26] Advanced age and prostate cancer specific mortality among geriatric patients with metastatic prostate cancer.
    Lu-Yao, Grace L.
    Kelly, William Kevin
    Chapman, Andrew E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [27] PROSTATE CANCER The best fit for enzalutamide in metastatic prostate cancer
    Pal, Sumanta K.
    Sartor, Oliver
    NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (09) : 504 - 506
  • [28] A prospective, multicenter, randomized phase II trial of best systemic therapy (BST) or BST plus definitive treatment (Surgery or Radiation) of the primary tumor in metastatic prostate cancer.
    Chapin, Brian Francis
    Mcguire, Sean Eric
    Wang, Xuemei
    Troncoso, Patricia
    Davis, John W.
    Navai, Neema
    Subudhi, Sumit Kumar
    Zurita, Amado J.
    Araujo, John C.
    Pettaway, Curtis Alvin
    Matin, Surena F.
    Pisters, Louis L.
    Ward, John Francis
    Tu, Shi-Ming
    Wang, Jennifer
    Le, Ott
    Logothetis, Christopher
    Aparicio, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Systemic oncolytic virotherapy for prostate cancer.
    Tien Nguyen
    Barry, Michael A.
    CANCER RESEARCH, 2018, 78 (16) : 57 - 58
  • [30] Underutilization of local salvage therapy after radiation therapy for prostate cancer
    Henry Tran
    Kwok, Jaime
    Pickles, Tom
    Tyldesley, Scott
    Black, Peter C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (05) : 701 - 706
12345